Eurasian
Pharma Awards 2025

Driving Inspiration. Shaping the Future.

Villa Brasserie, Tashkent, Uzbekistan
7 October

For the sixth year in a row, the Global Pharmaceutical Leaders’ Club invites pharmaceutical manufacturers, distributors, and pharmacy chains to participate in the Eurasian Pharma Awards competition.

We are looking for outstanding success stories from companies operating in the markets featured in the 2025 Eurasian Pharmaceutical Summit program: Uzbekistan, Kazakhstan, Azerbaijan, Kyrgyzstan, Belarus, Armenia, Georgia, Moldova, Turkmenistan, Tajikistan, and Mongolia.

This is a great opportunity not only to gain international recognition, but also to strengthen your company’s image as a reliable partner and employer.

Share your achievements, innovations, and successful projects with industry peers — inspire others and reaffirm your place among the pharmaceutical elite of Central Asia, the Caucasus, and Eastern Europe!

To participate in the competition, applicants must complete the form on the official website. Applications will only be accepted from companies that have delegated representatives to attend the Eurasian Pharmaceutical Summit in 2025.

Submit your application Competition Timeline

In 2025, applications are accepted in 15 nomination categories

1

Company of the Year (International)

This award recognizes a company that has achieved outstanding results in international pharmaceutical markets, demonstrating success in expanding its presence, strengthening partnerships, and implementing innovative solutions across Central Asia, the Caucasus, and Eastern Europe.

2

Company of the Year (Local Manufacturer)

This nomination is for a company founded in one of the countries discussed at the Summit from Central Asia, the Caucasus, or Eastern Europe, which has significantly contributed to the development of the pharmaceutical industry in its home country. The company should have made progress in improving access to medical goods and services while contributing to the local economy and regional development.

3

Distributor of the Year

This award is for a distributor that has demonstrated exceptional performance in ensuring the reliability and efficiency of pharmaceutical product supply to the market in a country from Central Asia, the Caucasus, or Eastern Europe, while improving logistics and medicine accessibility for the population.

4

Pharmacy Chain of the Year

Award for a pharmacy chain that has significantly improved access to and quality of pharmaceutical services in its region by introducing retail innovations and ensuring a high level of customer service across Central Asia, the Caucasus, and Eastern Europe.

5

Leader of the Year

Award for a top executive in a pharmaceutical company who has played a key role in developing and strengthening the company’s or the industry’s position in the markets of Central Asia, the Caucasus, and Eastern Europe, demonstrating strategic thinking and effective leadership.

6

Female Leader of the Year in PharmaNew

Recognition of a female leader who has made a significant impact on the development of the pharmaceutical sector in the region by successfully managing projects and introducing innovative solutions to improve healthcare and access to medicines.

7

Exporter of the Year

Recognition of a company that has successfully expanded its export potential in international markets, earned strong trust in its products, and actively contributed to the globalization of the pharmaceutical industry.

8

Investment Project of the Year New

Award for a company that has implemented a significant investment project in the pharmaceutical sector across Central Asia, the Caucasus, and Eastern Europe, contributing to the development of infrastructure, local manufacturing, or logistics and supporting sustainable growth and industry competitiveness.

9

Corporate Social Responsibility Project of the Year

Award for a project that made a meaningful contribution to improving public health and well-being in the region, demonstrating innovative approaches to addressing social and environmental issues through pharmaceutical and medical initiatives.

10

Digital Project of the Year

Recognition of a project that successfully implemented digital solutions in the pharmaceutical sector, improving service accessibility and efficiency, and enhancing customer engagement in the markets of Central Asia, the Caucasus, and Eastern Europe.

11

Corporate Culture Development Initiative of the Year New

Award for a company that has introduced effective initiatives to strengthen corporate culture, improve workplace morale, and increase employee satisfaction, demonstrating the values and principles of responsible business in the pharmaceutical industry.

12

Marketing Project of the Year New

Recognition of a project that exemplifies the successful promotion of pharmaceutical products in the markets of Central Asia, the Caucasus, and Eastern Europe, using innovative marketing strategies and approaches that significantly boosted brand recognition and sales.

13

New Product Launch Campaign of the Year New

Award for a company that successfully launched a new pharmaceutical product in the region, delivering an effective marketing campaign and achieving strong commercial results.

14

Regulatory Strategy of the Year New

Award for a company that implemented a successful regulatory strategy, accelerating market entry and ensuring compliance with regulatory requirements.

15

Project of the Year for Engagement with the Medical Community New

This nomination recognizes a project that has significantly improved the effectiveness of collaboration between pharmaceutical companies and the medical community, resulting in broader access to innovative solutions and enhanced professional development for healthcare specialists.

Competition Timeline

Application deadline

Until September 15, 2025

Submit →
Evaluation

Until September 19, 2025

Awards ceremony

October 7, 2025. Venue

  • The completed application must be submitted no later than September 15, 2025 via the event website.
  • Additional supporting materials should be sent to pharma@iventu.co.uk. These materials may include press releases, documentation on the launch or implementation of new projects and products, marketing data demonstrating project success, recommendation letters, and partner testimonials.
  • The expert jury reserves the right to contact the applicant or nominee for additional information or clarification during the application review process.

Join our Telegram channel

For your convenience, we have created a telegram channel where news, latest updates, and other useful information will be published.

Join the channel